NCT01416389 2019-09-18A Study of LY2523355 in Participants With Breast CancerEli Lilly and CompanyPhase 2 Completed39 enrolled 16 charts
NCT01214629 2018-08-06A Study for Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed54 enrolled 23 charts
NCT01214642 2018-08-06A Dose-Escalation Study for Patients With Advanced CancerEli Lilly and CompanyPhase 1 Completed63 enrolled 23 charts